Adam Ficsor’s Longevity World Cup hosts a global contest where biohackers submit PhenoAge biological age measurements to rank participants by the gap between their biological and chronological age. The competition features annual seasons, generational leagues, and rotating aging clocks to reward top athletes with Bitcoin payouts, incentivizing ethical exploration of aging-reversal strategies and accelerating longevity research through community engagement.
Key points
PhenoAge blood test measures methylation-based biological age to quantify reversal.
Annual seasons feature rotating aging clocks and generational leagues for fair competition.
Bitcoin payouts incentivize biohackers to optimize interventions and contribute longevity data.
Q&A
What is the PhenoAge clock?
How does the Longevity World Cup measure aging?
What is Longevity Escape Velocity?
How can someone join the competition?
Are there privacy or ethical concerns?
Read full article
Academy
Biological Aging Clocks
Biological aging clocks are predictive models that estimate an organism’s biological age based on molecular markers across tissues. Unlike chronological age, which counts years since birth, biological age reflects the functional state of cells and systems. By comparing biological and chronological age, scientists and biohackers assess whether interventions slow, halt, or reverse aging processes.
Early efforts to quantify biological age focused on telomere length, the protective caps on chromosome ends that shorten with cell division. While telomere measurement offered insight, it proved variable across individuals and tissues. Advances in genomics and computational biology ushered in epigenetic clocks, which analyze DNA methylation patterns at specific CpG sites to reveal age-related changes with greater precision.
One of the most widely used epigenetic models, the Horvath clock, integrates methylation levels at hundreds of sites to predict age with a margin of error around three to four years. Building on this foundation, newer clocks such as PhenoAge and GrimAge incorporate clinical biomarkers and protein profiles, further linking methylation patterns to age-related health outcomes and mortality risk.
Transcriptomic and proteomic clocks: Besides epigenetic markers, researchers develop clocks based on gene expression profiles and protein abundance. Transcriptomic clocks analyze RNA sequencing data to model age-related shifts in gene activity, while proteomic clocks use mass spectrometry or aptamer-based platforms to quantify circulating proteins. Integrating multiomic data can enhance clock accuracy and link age estimates to underlying biological pathways.
Developing an epigenetic clock involves collecting methylation data from large cohorts spanning multiple ages, applying statistical methods to select the most informative CpG sites, and training machine learning algorithms to output an age estimate. Common techniques include linear regression, elastic net regularization, and random forest models. After training, clocks undergo validation on independent datasets to ensure accuracy and generalizability.
Applications and significance: Biological aging clocks serve as endpoints for evaluating lifestyle changes, dietary supplements, and experimental therapies. In research settings, investigators track changes in clock age over time to gauge intervention efficacy. In citizen science and competitions like the Longevity World Cup, participants submit clock measurements to benchmark aging reversal strategies. This gamified approach fuels data generation and community-driven discovery.
Ethical and social considerations: As aging clock measurements become accessible, privacy and data security emerge as concerns. Standardized consent, secure data storage, and transparent reporting practices are vital to maintain participant trust. Equitable access to clock assays and interventions ensures that aging research benefits diverse populations and avoids amplifying health disparities.
Future directions focus on improving causal interpretation of clock signals and integrating clocks with clinical endpoints. As clocks evolve, they may inform personalized aging interventions, optimize trial design for geroprotective drugs, and guide public health strategies. Understanding clock dynamics at the single-cell level represents an emerging frontier, promising finer resolution of aging processes and target identification.
By demystifying molecular aging mechanisms and enabling quantitative assessment, biological aging clocks are central to the vision of extending healthspan and achieving resilience against age-related diseases.